Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Diabetes
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Diabetes
    TopAbstracts in Diabetes 01/06/2009 - (DGNews)
    TopAbstracts in Diabetes 12/30/2008 - (DGNews)
    TopAbstracts in Diabetes 12/23/2008 - (DGNews)
    Pioglitazone Hydrochloride Approved as Concomitant Therapy With Biguanides for Type 2 Diabetes in Japan - (DGNews)
    Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes - (N Engl J Med)

    News archive

     Recent webcasts/CME - Diabetes
      Achieving Glycemic Control in Type II Diabetes: Where Are We in 2008?
      Managing FPG and PPG With Incretin-Based Therapies: A Therapeutic Double Play
      Current Concepts in Diagnosing and Treating MRSA in the Diabetic Foot
      Diabetes: Treatment of Type 2 Diabetes and the Role of Insulin
      Aggressive Management of Type 2 Diabetes to Prevent Macrovascular Complications

      Webcasts/CME archive

       Recent cases - Diabetes
        Atypical Ketosis-Prone Diabetes
        Bilateral Dystonia in Type 1 Diabetes: A Case Report
        Lisfranc Fracture-Dislocation Precipitating Acute Charcot Arthopathy in a Neuropathic Diabetic Foot: A Case Report
        Emphysematous Pyelonephritis in Type II Diabetes: A Case Report of an Undiagnosed Ureteric Colic
        Vitamin D and Diabetes: Improvement of Glycemic Control with Vitamin D3 Repletion

        Cases archive
          




        my personal edition > diabetes > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Gene Variation in Diabetics Associated With Increased Risk of Coronary Artery Disease

        CHICAGO -- November 25, 2008 -- Patients with type 2 diabetes who have poor glycaemic control and a genetic variation on chromosome 9p21 have an increased risk of coronary artery disease (CAD), according to a study in the November 26 issue of the Journal of the American Medical Association.

        Alessandro Doria, MD, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, and colleagues examined the association of this genetic variant with CAD in individuals with type 2 diabetes and whether the association is affected by poor glycaemic control.

        The researchers conducted 2 studies. The first study included 734 patients with type 2 diabetes (322 with angiographically diagnosed CAD and 412 with no evidence of CAD) who were recruited between 2001 and 2006. The second study included 475 patients with type 2 diabetes whose survival status was monitored from their recruitment between 1993 and 1996 until December 31, 2004.

        Participants for both studies were tested for a representative single-nucleotide polymorphism of chromosome 9p21 and characterised for their long-term glycaemic control by averaging measurements of haemoglobin A1C taken in the years before study entry.

        The researchers found that relative to the CAD risk for patients with neither a 9p21 risk gene variant nor poor glycaemic control, the odds for CAD among participants having 2 risk-gene variants but not poor glycaemic control was increased 2-fold, whereas the odds for CAD among study participants with the same genotype but poor glycaemic control were increased 4-fold.

        The interaction was stronger when a measure of long-term glycaemic control was used for participants having 2 risk-gene variants and a history of poor glycaemia, and for participants with the same genotype but not long-term poor glycaemia.

        A similar interaction between the 9p21 variant and poor glycaemic control was observed with respect to the rate of death after 10 years.

        "In conclusion, 9p21 [variant] and poor glycaemic control interact in determining the odds of CAD in type 2 diabetes. This finding may have implications for our understanding of atherogenesis in diabetes and for the design of more effective prevention strategies," the authors wrote.

        "More broadly, it illustrates the complex etiology of multifactorial disorders and highlights the importance of accounting for gene-environment and gene-gene interactions in the quest for genetic factors contributing to these conditions."

        SOURCE: Journal of the American Medical Association



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send